Bosten Technology

About Bosten Technology

Boston Cognitive operates at the intersection of neuroscience and digital health, providing a suite of tools for the early detection and management of cognitive decline. The company's foundation is built upon the work of its founder, neuroscientist Dr. Andrey Vyshedskiy, who holds a Ph.D. from Boston University and has an extensive background in brain function and cognitive science. His research initially led to the creation of AlzLife, a platform that integrated 40Hz light and sound stimulation with cognitive exercises, based on studies suggesting that 40Hz gamma rhythms are essential for functions like memory.

From this foundation, Dr. Vyshedskiy developed the company's core product, the Boston Cognitive Assessment (BoCA™). Originally a tool for academic research, BoCA™ is now a commercially available, self-administered digital test that evaluates eight cognitive domains in approximately 10 minutes. It is designed for repeated use with minimal practice effects, making it suitable for longitudinal tracking of cognitive performance for individuals, researchers, and clinicians. The company's evolution also included a direct-to-consumer initiative called BellCurveAndMe, which provided valuable insights into user needs and helped refine its clinical strategy.

The business model targets healthcare providers, health systems, and researchers. Revenue is generated through its platform, which offers reimbursable services under existing CPT codes for cognitive assessment. The full platform includes the quick Boston Cognitive Screen™, the comprehensive BoCA™ assessment, and the Boston Cognitive Care Plan™, which helps providers develop personalized management plans for patients. For individuals, the company offers the Boston Cognitive Program, an AI-guided lifestyle program focused on brain-healthy habits. This integrated approach allows Boston Cognitive to serve a continuum of care, from proactive wellness and screening to clinical management of cognitive health, addressing a significant market need driven by an aging global population.